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1.1. Small molecule inhibitors of protein arginine deiminase 3
The protein arginine deiminases (PADs) are enzymes that
catalyse the hydrolytic deimination of peptidic arginine guanidine
groups (1) to generate ureas (2). There are several functionally
distinct PAD subtypes identiﬁed that exhibit tissue-speciﬁc
occurrence. Dysregulation of PAD activity has been shown to be
responsible for a number of human diseases including psoriasis
(PAD1), multiple sclerosis (PAD2) and autoimmune diseases
(PAD4). Dysregulation of PAD3 has been associated with the
neurodegenerative response to spinal cord injury. A recent
publication has described the discovery of PAD3 subtype selective
inhibitors discovered by the modiﬁcation of substrates identiﬁed
from libraries of guanidines [1].HN
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(SAS) in which non-peptide substrate fragments are optimised and
then converted to inhibitors by, in this case, replacement of the
guanidine with the irreversibly binding chloromethylamidine
group found in the previously described PAD inhibitor, Cl-amidine
(3). The goal from this study was to ﬁnd compounds with both high
inhibitory activity and PAD subtype selectivity, focusing primarily
on PAD3 where selective inhibitors have not previously been
identiﬁed.HN
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E-mail: nterrett@ensembletx.comA library of over 200 guanidine substrates was prepared using
parallel solution-phase synthesis in a one-step guanylation process
from commercially available amines. The compounds were
puriﬁed by reverse-phase chromatography and screened against
PAD3 using a colorimetric assay that detected urea-containing
products. The relative cleavage efﬁciency of the substrates
correlates with kcat/Km and compounds such as the hydantoin (4,
kcat/Km = 3.5) were identiﬁed as good substrates with potential
for further structural modiﬁcation. Indeed, optimization of com-
pound 4 resulted in an analogue (5) that was cleaved almost three
times as efﬁciently (kcat/Km = 9.2).Inhibitors based on these substrates were readily obtained by
conversion of the guanidine to the chloroacetamide derivative.
A number of substrates with the highest relative kcat/Km values
were thus modiﬁed, and the most potent inhibitor observed, based
on compound 5, was the derivative 6, with a PAD3 kinact/KI value of
17,400 (min1 M1).O
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age efﬁciency correlated reasonably well with inhibitory potency,
although the correlation did not extend across series. Compound
6 showed good selectivity for PAD3 over PAD1, but more modest
selectivity over PADs 2 and 4. Other compounds such as 7 showed
greater selectivity for PAD3 over all other PADs and provide a
promising starting point for further selective PAD inhibitor
development.2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
The use of covalent linkers as hydrogen bond surrogates for the
stabilisation of a-helical secondary structures, resulting in the
formation of macrocycles, is a validated approach to potentially
biologically active compound libraries. For these purposes, a
straightforward synthetic pathway has been developed, employing
natural amino acids bearing usual protecting groups and mediated
through two Fukuyama–Mitsunobu alkylation reactions on unpro-
tected 1,3-propanediol on solid phase. The linear precursors were
obtained in good purity and moderate yields, and the ﬁnal cyclisa-
tion step was carried out in solution [2].
An efﬁcient protocol for the solid-phase synthesis of 2,4-disub-
stituted 5-carbamoyl-thiazole derivatives has been developed.
After the reaction was investigated in solution, the polymer-sup-
ported synthesis route was progressed using a traceless sulﬁde lin-
ker. The solid-phase synthetic protocol started with the Thorpe–
Ziegler type cyclisation of 2-chloroacetamide and polymer-bound
cyanocarboimidodithioate, derived from Merriﬁeld resin. The tar-
get 2,4-disubstituted 5-carbamoyl-thiazole derivatives were
obtained in good purities and overall yields [3].
2.2. Solution-phase synthesis
A simple synthetic method to generate bis-armed spirocycles in
a diversity-oriented manner has been developed. The approach
employs a two-directional [2+2+2] co-trimerisation and [4+2]
cycloaddition reaction as key steps. The sultine derivatives pro-
duced are themselves valuable latent diene equivalents suitable
for Diels–Alder reactions to assemble various spirocycles under
mild reaction conditions [4].
A general methodology for the three step synthesis of macro-
cyclic peptidomimetic ﬂuorophores with a range of ring size from
15 to 18 has been described. Mannich-type chemistry between
halogen-functionalised long chain alkyl nitriles and aldehydes or
ketones, in which one of them is decorated with an alkyne func-
tionality, has been undertaken. This provides the key precursor
for an intramolecular copper-catalysed [3+2] azide-alkyne
cycloaddition which generates target macrocycles which also obey
Lipinski’s rule of ﬁve [5].
2-Pyrones, pyridones and quinolones represent classes of
molecules with remarkable and diverse biological activity. As the
introduction of a triﬂuoromethyl group to a molecule can have dra-
matic and beneﬁcial effects in terms of lipophilicity and bioavail-
ability, a route to afford a library of novel triﬂuoromethylated
2-pyrones, 2-pyridones and a 2-quinolone has been reported.
Reactions using methyl ﬂuorosulfonyldiﬂuoroacetate as the
triﬂuoromethylating agent have generated products in moderate
to good yield [6].
2.3. Scaffolds and synthons for combinatorial libraries
Heterocyclic naphthoquinones represent valuable scaffolds in
medicinal chemistry. A recent paper describes the efﬁcientstereoselective synthesis of new dihydropyrano- and dihydrofura-
nonaphthoquinones by means of a one-pot multicomponent reac-
tion using 2-hydroxy-1,4-naphthoquinone, an aromatic aldehyde
and ethyl 4,4,4-triﬂuoroacetoacetate or a pyridinium bromide [7].
2.4. Solid-phase supported reagents
Amberlyst 15(H) has been shown for the ﬁrst time to be
effective as a green catalyst in promoting the Povarov reaction
between an imine, derived from the aryl/heteroaryl aldehydes
and 1H-indazol-6-amine, and indole/5-bromo-1H-indole.
Representative candidates from the library of exo-1,6,7,7a,12,
12a-hexahydroindolo[3,2-c]pyrazolo[3,4-f]quinolines thus pro-
duced were tested for their sirtuin (Sir-2) inhibitory activity using
a yeast-based assay [8].
The ﬁrst cellulose-supported copper nanoparticles that catalyse
decarboxylative nitration of cinnamic and benzoic acids have been
described. (E)-Nitrooleﬁns were obtained stereoselectively in
excellent yields under mild and convenient reaction conditions.
This novel and efﬁcient catalytic system was also successfully
applied in nitrodecarboxylation of a few benzoic acids providing
major advantages over existing protocols [9].
Polystyrene-supported DABCO has been employed for the ﬁrst
time as a recyclable heterogeneous basic catalyst for one-pot syn-
thesis of b-phosphonomalonates via tandem Knoevenagel–
phospha–Michael reaction at room temperature. The reaction con-
ditions are mild, the method is operationally simple and the cata-
lyst could be easily separated from the reaction mixture by
ﬁltration and recycled six times without activity loss [10].
2.5. Novel resins, linkers and techniques
Three Cr(III)–salen catalysts supported onto macrocyclic oligo-
meric cyclooctene through linkers of different lengths have been
synthesised. The inﬂuence of the linker length and the oligomeric
support on the activity and the enantioselectivity of the catalysts
has been investigated in the asymmetric ring opening of a meso-
epoxide and the kinetic resolution of terminal epoxides. For both
reactions, all three catalysts exhibited signiﬁcantly higher catalytic
efﬁciency than the unsupported monomeric Cr(III)–salen catalyst
[11].
2.6. Library applications
A number of thiazolidinone compounds have cytoselective tox-
icity toward non-small cell lung cancer (NSCLC) cells and drug-re-
sistant NSCLC cells while showing low toxicity to normal human
ﬁbroblasts (NHFB). However, as this class of compound generally
has very low aqueous solubility, two lead-optimisation libraries
were designed and prepared. The compounds were investigated
using simultaneous high-throughput solubility and cytotoxicity
assays [12].
Structure-based and pharmacophore-based virtual screening in
combination with combinatorial chemistry and X-ray crystallogra-
phy has led to the discovery of a new class of benzothiadiazole
dioxide analogues with functional activity as RAR-related orphan
receptor (ROR) C inverse agonists. An early lead compound exhib-
ited RORC inhibition in a cell-based reporter gene assay.
Optimisation yielded compounds with enhanced RORC inverse
agonist activity, with the most active compound showing an IC50
value of 440 nM in a human PBMC assay [13].
A high-throughput screen of the National Institutes of Health
Molecular Libraries Small Molecule Repository (NIH MLSMR) has
been undertaken, measuring the transfer of the ﬂuorescent lipid
DiI from HDL particles to CHO cells overexpressing Scavenger
Receptor, Class B, Type I (SR-BI). A new series of 8-membered
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particles mediated by SR-BI were identiﬁed. These compounds
are part of a previously reported diversity-oriented synthesis
(DOS) library prepared via a build-couple-pair approach. Detailed
structure–activity relationship (SAR) studies were performed with
a selection of the original library, as well as additional analogues
prepared via solution phase synthesis [14].
A simple, mild and efﬁcient method for the synthesis of
pyrazolopyridine-based spirooxindoles by the three-component
reaction has been developed using sulfamic acid (H2NSO3H) as
a green catalyst. After completion of the reaction, the
catalyst could be recovered and reused for up to four cycles
without loss in catalytic activity. Employing this method, a
library of 34 compounds has been synthesised and investigated
for their cytotoxicity against a panel of three human cancer cell
lines [15].
A recent publication describes the use of the celecoxib scaffold,
which exhibits several activities against different pathogens, in the
design and focused synthesis of a library of 64 compounds seeking
anti-tuberculosis activity. For the primary screen, a biolumines-
cence-based assay was used, generated by constructing a lucifer-
ase-expressing reporter Mycobacterium tuberculosis strain which
contains the entire bacterial Lux operon cloned in a mycobacterial
integrative expression vector. Through the screening of this library,
six hit compounds with high in vitro anti-mycobacterial activity
were identiﬁed [16].
A library of 33 new N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)pro-
panamides, 2-(3-methyl-2,5-dioxopyrrolidin-1-yl)propanamides,
and 2-(2,5-dioxopyrrolidin-1-yl)butanamides as potential new
hybrid anticonvulsant agents has been constructed. These hybrid
molecules join the chemical fragments of well-known antiepileptic
drugs and initial anticonvulsant screening was performed in
mice using the maximal electroshock seizure and subcutaneous
pentylenetetrazole seizure tests [17].
D-Luciferin is widely used as a substrate in luciferase-catalysed
bioluminescence assays for in vitro studies. However, little is
known about cross reactivity and potential interference of D-lu-
ciferin with other enzymes, although it has been found that ﬁreﬂy
luciferin inhibits the CDK2/Cyclin A protein kinase. Inhibition pro-
ﬁling of D-luciferin over a 103-protein kinase panel showed
signiﬁcant inhibition of a small set of protein kinases. Inhibition
proﬁling of a 16-member focused library derived from D-luciferin
conﬁrms that this represents a binding chemotype. Observation
of inhibitory activity and initial SAR information promises to be
useful for future protein kinase inhibitor design with related scaf-
folds [18].
Whole-cell screening of a library of 2,5-disubstituted thiazole
compounds previously revealed a lead compound exhibiting
potent antimicrobial activity against Methicillin-resistant
Staphylococcus aureus (MRSA). A recent study just published, con-
ducting a more rigorous analysis of the structure–activity relation-
ship of this compound, reveals that a nonpolar, hydrophobic
functional group is favoured at thiazole-C2 and an ethylidenehy-
drazine-1-carboximidamide moiety is necessary at C5 for the com-
pound to possess activity against MRSA [19].
With the aim of developing a suitable radiotracer for brain
imaging of the serotonin 4 receptor subtype (5-HT4R) using single
photon emission computed tomography (SPECT), a library of di-
and triazaphenanthridines has been synthesised with lipophilicity
values in the range expected to favour brain penetration. A pre-
ferred compound exhibited a binding afﬁnity value of 0.094 nM
toward human 5-HT4R and high selectivity over other serotonin
receptor subtypes. In vivo SPECT imaging studies and competition
experiments demonstrated that decreased lipophilicity compared
with earlier compounds allowed a more speciﬁc labelling of the
5-HT4R brain-containing regions [20].References
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